Phenotypic variability Flashcards

1
Q

How do gene/environmental interactions contribute towards phenotypic variance?

A

Contribute to the progression and outcome of the disease for each patient.
Affects prognosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is multiple endocrine neoplasia type 1 (MEN1)?

A

Increased chance of developing adenomas within endocrine tissue.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Which genes are mutated within MEN1?

A

Mutation within tumor suppressor gene (synthesizes menin).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the inheritance pattern for MEN1?

A

Autosomal dominant inherited conditions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

How do environmental triggers affect the phenotypic expression of MEN1?

A

Promotes tumour formations, tumours associated with parathyroid gland, pancreatic islet & anterior pituitary.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Which protein is mutated within hereditary hemochromatosis?

A

HFE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Which receptor is bound to transferrin, enabling iron entry into hepatocytes?

A

Transferrin receptor I

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Which hormone regulates iron release within enterocytes?

A

Hepcidin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the pathophysiology of hereditary hemochromatosis?

A

HFE protein regulates iron levels within hepatocytes by preventing transferrin from binding to transferrin receptor I. HFE mutation reduces iron transportation into the live, therefore hepcidin synthesis is reduced. This causes increase ferroportin release of iron from enterocytes, resulting in iron overload.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What percentage of patients with hereditary hemochromatosis have clinically relevant iron accumulation?

A

10%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Why are women more likely to be protected from hereditary hemochromatosis?

A

Menstrual bleeding

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are genetic modifiers?

A

Life-course of disease and symptoms present are modified by presence of other genes. These gens can either improve or worsen the condition.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Name three cystic fibrosis genetic modifiers

A

delf5f08, TFB1 gene, FCGR2A

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How does the delf5f08 gene alter the phenotypic expression of CF?

A

Homozygotes of the gene mutation classified with severe/mild lung disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

How does the TGFB-1 gene alter the phenotype of CF?

A

Encodes for transforming growth factor beta-1, variants associated with severe lung disease phenotype. Increases lung inflammation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Which gene increases the risk of developing respiratory tract infections with patients of CF?

A

Immunoglobulin Fc-gamma receptor II (FCGR2A)

Variant increases chance of developing chronic pseudomonas aeruginosa infection by 4 fold

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Which is VHL?

A

Von-Hippel Lindau syndrome
Dominant inherited familial cancer syndrome predisposing to a variety of malignant and benign neoplasms. Retinal, cerebellar and spinal hemangioblastoma, renal cell carcinoma, pheochromocytoma, and pancreatic tumors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Which gene modifier alters the phenotype of VHL?

A
Cyclin D1 (CCND1)
G allele increases number of retinal angiomas compared with AA homozygotes. G allele associated with earlier diagnosis of CNS hemangioblastoma by 2 fold.
19
Q

What is the function performed by the cyclin d1 receptor?

A

Cyclin d1 regulator of cell cycle progression, overexpression leads to the development of cancer

20
Q

Which protein is involved in muscular dystrophy?

A

Dystrophin

21
Q

Which are the two main muscular dystrophy conditions?

A

Becker muscular dystrophy

Duchenne muscular dystrophy

22
Q

When is the age of onset of Becker muscular dystrophy?

A

12 years old, loss of ambulation varies from adolescence onwards

23
Q

When does death usually occur with patients expressing BMD?

A

Death in the fourth/fifth decade

24
Q

When is the age of onset for DMD?

A

4.6 years

25
Q

When do patients with DMD become wheelchair dependent?

A

10 years

26
Q

What percentage of patients with DMD develop cardiac failure?

A

15% of patients, with a median age of 21.5 years

27
Q

When is the median death for patients with DMD?

A

17 years

28
Q

Which type of gene mutation is associated with muscular dystrophy disorders?

A

Deletions

29
Q

How does a gene mutation cause DMD?

A

A deletion within the dystrophin gene causes a frameshift deletion, thus this means no active dystrophin is produced (triplet of a sequence of bases altered, altering codon sequence)
Presence of premature stop codon

30
Q

How does BMD mutation occur?

A

Deletion causes stop codon, therefore a truncated functional dystrophin protein is produced

31
Q

What are unstable gene mutations?

A

Diseases termed trinucleotide repeat disorders, the underlying cause of the disease is trinucleotide repeat expansion. Mutation whereby a region of three repeated nucleotides within the genome increases in frequency during DNA replication.

32
Q

Below which number of repeats conforms for gene stability and protein functionality?

A

27 repeats

33
Q

What is DNA slippage?

A

Increased repeat frequency exceeds the stability threshold, whereby mutation loses stability during DNA replication and the number of repeats increases during subsequent rounds of DNA replication – Increase trinucleotide repeats, changing protein function

34
Q

What is the relationship between repeat frequency and phenotypic severity?

A

Greater number of repeats results in increased severity of phenotype. Characterized by an earlier onset of disease, greater severity of symptoms in each succeeding generation as the number of repeats increases.

35
Q

Which trinucleotide sequence is associated with Huntington’s disease?

A

CAG

36
Q

What causes Huntington’s disease?

A

Caused by the expansion of the region of the huntingtin gene (Cytosin, adenine, guanine), monogenetic (affecting only one gene), a neurodegenerative disorder

37
Q

What is the inheritance pattern for Huntington’s disease?

A

Autosomal dominance

38
Q

Which amino acid is encoded by CAG?

A

Glutamate

39
Q

What is formed from multiple glutamate polypeptide sequences?

A

Poly Q tract (Polyglutamine)

40
Q

Fewer than ___ CAG repeats is considered stable?

A

27

41
Q

Between which CAG repeat range forms an intermediate phenotype?

A

27-35 repeats

42
Q

What number of CAG repeats forms the characteristic phenotype?

A

36-39 (Not all carries affected by disease)

43
Q

What number of CAG repeats affects all carriers?

A

40+